BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 498077)

  • 1. Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma.
    Vaage J; Costanza ME
    Cancer Res; 1979 Nov; 39(11):4466-71. PubMed ID: 498077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice.
    Heppner GH; Calabresi P
    Cancer Res; 1977 Dec; 37(12):4580-3. PubMed ID: 303542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P
    Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy.
    Emerman JT; Siemiatkowski J
    Cancer Res; 1984 Apr; 44(4):1327-32. PubMed ID: 6704951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between tumor growth characteristics and preferential sites of growth.
    Vaage J
    J Natl Cancer Inst; 1984 May; 72(5):1199-203. PubMed ID: 6585595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
    Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
    Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on metastases of drug therapy during developing and established tumor immunity.
    Vaage J; Costanza ME
    Int J Cancer; 1983 Dec; 32(6):759-63. PubMed ID: 6654527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.
    Fisher B; Rubin H; Saffer E; Wolmark N
    Cancer Res; 1976 Aug; 36(8):2714-9. PubMed ID: 1277181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
    Vaage J; Agarwal S
    Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
    Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
    Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combination estrogen:cyclophosphamide treatment on the growth of the MXT transplantable mammary tumor in the mouse.
    Markaverich BM; Medina D; Clark JH
    Cancer Res; 1983 Jul; 43(7):3208-11. PubMed ID: 6850631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherent changes in the in vivo growth characteristics of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1980 Oct; 40(10):3495-3501. PubMed ID: 7438036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
    Soloway MS
    Natl Cancer Inst Monogr; 1978 Dec; (49):327-32. PubMed ID: 748788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A time factor in the success or failure of immune rejection of transplanted tumors.
    Vaage J
    Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of maltose tetrapalmitate on tumor vascularization and tumor growth.
    Benrezzak O; Bissonnette E; Madarnas P; Nigam VN
    Anticancer Res; 1989; 9(6):1815-8. PubMed ID: 2483306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methylprednisolone on the cell kinetic response of C3H/HeJ mammary tumors to cyclophosphamide and adriamycin.
    Braunschweiger PG; Schiffer LM
    Cancer Res; 1979 Oct; 39(10):3812-5. PubMed ID: 476617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell kinetic-directed sequential chemotherapy with cyclophosphamide and adriamycin in T1699 mammary tumors.
    Braunschweiger PG; Schiffer LM
    Cancer Res; 1980 Mar; 40(3):737-43. PubMed ID: 7471093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.